Related references
Note: Only part of the references are listed.DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer
Lindsey Low et al.
HUMAN GENE THERAPY (2009)
Physiological Effects of High- and Low-Voltage Pulse Combinations for Gene Electrotransfer in Muscle
Pernille Hojman et al.
HUMAN GENE THERAPY (2008)
Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor
Adil I. Daud et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cardiovascular gene therapy: current status and therapeutic potential
M. M. Gaffney et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease:: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment
D. J. Stewart et al.
GENE THERAPY (2006)
Cardiovascular gene delivery: The good road is awaiting
L. P. Brewster et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
In vivo electroporation for gene therapy
Loree C. Heller et al.
HUMAN GENE THERAPY (2006)
Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals
DA Dean
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Direct intramyocardial plasmid vascular endothelial growth factor-A165-gene therapy in patients with stable severe angina pectoris -: A randomized double-blind placebo-controlled study:: The Euroinject One trial
J Kastrup et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Adenoviral-mediated transfer of vascular endothelial growth factor 121 cDNA enhances myocardial perfusion and, exercise performance in the nonischemic state
P Schalch et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2004)
Gene therapy progress and prospects: Electroporation and other physical methods
DJ Wells
GENE THERAPY (2004)
One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients
FD Fortuin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Progress and prospects: naked DNA gene transfer and therapy
H Herweijer et al.
GENE THERAPY (2003)
Gene therapy progress and prospects: Nonviral vectors
T Niidome et al.
GENE THERAPY (2002)
Angiogenic GENe Therapy (AGENT) trial in patients with stable angina pectoris
CL Grines et al.
CIRCULATION (2002)
Effects of intramyocardial injection of phVEGF-A165 as sole therapy in patients with refractory coronary artery disease -: 12-month follow-up:: Angiogenic gene therapy
N Sarkar et al.
JOURNAL OF INTERNAL MEDICINE (2001)
Nonviral vectors in the new millennium: Delivery barriers in gene transfer
M Nishikawa et al.
HUMAN GENE THERAPY (2001)
Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle
ML Lucas et al.
MOLECULAR THERAPY (2001)
Therapeutic perspectives of in vivo cell electropermeabilization
LM Mir
BIOELECTROCHEMISTRY (2001)
Efficient nonviral cutaneous transfection
J Glasspool-Malone et al.
MOLECULAR THERAPY (2000)
Share Paper
